全文获取类型
收费全文 | 18423篇 |
免费 | 1746篇 |
国内免费 | 556篇 |
专业分类
耳鼻咽喉 | 57篇 |
儿科学 | 351篇 |
妇产科学 | 320篇 |
基础医学 | 1685篇 |
口腔科学 | 269篇 |
临床医学 | 3069篇 |
内科学 | 4696篇 |
皮肤病学 | 291篇 |
神经病学 | 1105篇 |
特种医学 | 322篇 |
外国民族医学 | 4篇 |
外科学 | 1080篇 |
综合类 | 2780篇 |
现状与发展 | 6篇 |
预防医学 | 794篇 |
眼科学 | 163篇 |
药学 | 1694篇 |
8篇 | |
中国医学 | 720篇 |
肿瘤学 | 1311篇 |
出版年
2024年 | 23篇 |
2023年 | 312篇 |
2022年 | 334篇 |
2021年 | 705篇 |
2020年 | 785篇 |
2019年 | 725篇 |
2018年 | 717篇 |
2017年 | 727篇 |
2016年 | 708篇 |
2015年 | 789篇 |
2014年 | 1148篇 |
2013年 | 1418篇 |
2012年 | 1048篇 |
2011年 | 1007篇 |
2010年 | 833篇 |
2009年 | 785篇 |
2008年 | 733篇 |
2007年 | 823篇 |
2006年 | 607篇 |
2005年 | 636篇 |
2004年 | 547篇 |
2003年 | 543篇 |
2002年 | 456篇 |
2001年 | 461篇 |
2000年 | 373篇 |
1999年 | 338篇 |
1998年 | 318篇 |
1997年 | 271篇 |
1996年 | 242篇 |
1995年 | 254篇 |
1994年 | 234篇 |
1993年 | 162篇 |
1992年 | 170篇 |
1991年 | 166篇 |
1990年 | 132篇 |
1989年 | 125篇 |
1988年 | 127篇 |
1987年 | 112篇 |
1986年 | 85篇 |
1985年 | 155篇 |
1984年 | 143篇 |
1983年 | 95篇 |
1982年 | 97篇 |
1981年 | 90篇 |
1980年 | 56篇 |
1979年 | 29篇 |
1978年 | 21篇 |
1977年 | 19篇 |
1976年 | 17篇 |
1975年 | 7篇 |
排序方式: 共有10000条查询结果,搜索用时 250 毫秒
1.
Dongbing Lai Emma C. Johnson Sarah Colbert Gayathri Pandey Grace Chan Lance Bauer Meredith W. Francis Victor Hesselbrock Chella Kamarajan John Kramer Weipeng Kuang Sally Kuo Samuel Kuperman Yunlong Liu Vivia McCutcheon Zhiping Pang Martin H. Plawecki Marc Schuckit Jay Tischfield Leah Wetherill Yong Zang Howard J. Edenberg Bernice Porjesz Arpana Agrawal Tatiana Foroud 《Alcoholism, clinical and experimental research》2022,46(3):374-383
2.
3.
4.
5.
Platelets are needed to prevent or arrest bleeding and aggregate at the site of injury upon vascular damage. Platelets express receptors for estrogens which might affect the function of the platelets and their hemostatic ability. The aim was to identify possible differences in platelet function related to age, gender, and phases of the menstrual cycle by use of impedance aggregometry with Multiplate. In the first part of the study, platelet function was assessed in 60 healthy individuals (30 men and 30 women) in each of three age groups (20–25, 40–45, and 60–65 years). In the second part of the study, the platelet function was analyzed on four occasions during the menstrual cycle in women without oral contraceptives (OCs) (n = 17) and compared to 19 women on OCs and 18 men of similar age (20–40 years). For the women on OCs, aggregation was analyzed once during the tablet-free week and once late during the period with OCs. The men were sampled once. Women of younger age (<45 years) had significantly higher agonist-induced aggregation response than both men and post-menopausal women (60–65 years). The agonist-induced aggregation response did not differ between phases of the menstrual cycle or OC use. The results suggest that estradiol and/or progesterone affect spontaneous aggregation since it was found to be lowest in the mid-luteal phase. Spontaneous aggregation was significantly lower in women on OCs than in both men and women without OCs. Our findings indicate that fertile age is associated with higher aggregation response capacity of the platelets, possibly to prevent excessive bleeding during menstruation, but this response capacity is not altered during the menstrual cycle or by use of OCs. 相似文献
6.
Krishna S. Iyer 《Platelets》2020,31(4):474-482
Abstract Platelets are small, anucleated effector cells that play an important role in linking the hemostatic and inflammatory processes in the body. Platelet function is known to be altered under various inflammatory conditions including aging. A gain in platelet function during aging can increase the risk of thrombotic events, such as stroke and acute myocardial infarction. Anti-platelet therapy is designed to reduce risk of serious cerebrovascular and cardiovascular events, but the adverse consequences of therapy, such as risk for bleeding increases with aging as well. Age-associated comorbidities such as obesity, diabetes, and hyperlipidemia also contribute to increased platelet activity and thus can enhance the risk of thrombosis. Therefore, identification of unique mechanisms of platelet dysfunction in aging and in age-associated comorbidities is warranted to design novel antiplatelet drugs. This review outlines some of the current areas of research on aging-related mechanisms of platelet hyperactivity and addresses the clinical urgency for designing anti-platelet therapies toward novel molecular targets in the aging population. 相似文献
7.
8.
Primary cutaneous anaplastic large cell lymphomas with 6p25.3 rearrangement exhibit particular histological features 下载免费PDF全文
9.
10.
目的:探讨中期正电子发射型计算机断层显像(positron emission tomography-computed tomography,PET-CT)Deauville五分法(Deauville five-point scale,5-PS)与最大标准摄取值缩减率(maximum standard uptake value variation,△SUVmax)两种图像判读法在弥漫性大B细胞淋巴瘤(diffuse large B-cell lymphoma,DLBCL)患者预后评估中的应用价值。方法:回顾性分析2012年10月至2018年6月重庆医科大学附属第一医院收治的94例DLBCL患者资料。采用Kaplan-Meier法及Cox比例风险回归模型进行生存资料分析,计算并采用χ2检验比较5-PS和△SUVmax对DLBCL患者预后预测的能力。结果:5-PS和△SUVmax分别以4分、86%进行分组。5-PS<4分组、△SUVmax≥86%组的患者无进展生存期(progression free survival,PFS)和总生存期(overall survival,OS)均优于5-PS≥4分组、△SUVmax<86%组的患者(P<0.05)。△SUVmax与5-PS对患者PFS和OS均有影响,较高的阴性预测值(89.4%,93.6%;76.1%,85.9%),较低的阳性预测值(48.9%,31.9%;47.8%,34.8%),并且△SUVmax对于患者的敏感性优于5-PS(82.1%,83.3%vs.39.3%,44.4%)。单因素分析中国际预后指数(international prognostic index,IPI)(P=0.007)、△SUVmax(P<0.001)、5-PS(P=0.014)及基线全身肿瘤代谢体积(total metabolic tumor volume,TMTV)(P=0.001)与PFS相关,△SUVmax(P=0.014)、5-PS(P=0.033)、TMTV(P=0.004)与OS相关;多因素分析显示TMTV是OS的独立预测因子(P=0.005),△SUVmax和TMTV是PFS的独立预测因子(P=0.002,P=0.020),并且△SUVmax<86%且高水平TMTV患者较低TMTV患者的PFS明显缩短(P=0.001)。结论:5-PS和△SUVmax均能初步评估DLBCL患者预后,但△SUVmax具有更高的预测价值,并且联合基线TMTV可以对DLBCL患者进行再次危险度分层。 相似文献